More about the book
This rewritten and updated second edition provides comprehensive information on the wide-ranging applications of statistics in the pharmacological field. Focusing on practical aspects, it sets out to bridge the gap between industry and academia.;Reflecting the changes that have taken place since publication of the first edition, this volume covers new topics such as: cancer clinical trials, clinical trials of AIDS patients and animal tumorigenicity studies; the development of antiepileptic drugs; the role of epidemiology in postmarketing trials and adverse drug experience; computer-assisted new drug application (CANDA) submissions; contract research organizations; interim analysis in clinical trials; and room-temperature tests for the stability of drugs.;This work is intended as: a reference for statisticians, biostatisticians, pharmacologists, administrators, managers, and scientists in the pharmaceutical industry; and a text for graduate students taking courses in applied statistics or pharmaceutical statistics.
Book purchase
Statistics: Textbooks and Monographs - 140: Statistics in the Pharmaceutical Industry, Charles Ralph Buncher, Jia-Yeong Tsay
- Language
- Released
- 1993
- product-detail.submit-box.info.binding
- (Hardcover),
- Book condition
- Damaged
- Price
- €6.30
Payment methods
No one has rated yet.
- Title
- Statistics: Textbooks and Monographs - 140: Statistics in the Pharmaceutical Industry
- Subtitle
- 3rd Edition
- Language
- English
- Authors
- Charles Ralph Buncher, Jia-Yeong Tsay
- Publisher
- CRC Press
- Released
- 1993
- Format
- Hardcover
- Pages
- 592
- ISBN10
- 0824790731
- ISBN13
- 9780824790738
- Series
- Tags
- Non-Fiction, Science & Math, Mathematics, USA, Technology, Medicine, Drugs, Pharmacy, Medicines, Pharmaceuticals, Epidemiology
- Description
- This rewritten and updated second edition provides comprehensive information on the wide-ranging applications of statistics in the pharmacological field. Focusing on practical aspects, it sets out to bridge the gap between industry and academia.;Reflecting the changes that have taken place since publication of the first edition, this volume covers new topics such as: cancer clinical trials, clinical trials of AIDS patients and animal tumorigenicity studies; the development of antiepileptic drugs; the role of epidemiology in postmarketing trials and adverse drug experience; computer-assisted new drug application (CANDA) submissions; contract research organizations; interim analysis in clinical trials; and room-temperature tests for the stability of drugs.;This work is intended as: a reference for statisticians, biostatisticians, pharmacologists, administrators, managers, and scientists in the pharmaceutical industry; and a text for graduate students taking courses in applied statistics or pharmaceutical statistics.